Personal profile

Personal Statement

Charles Kennedy graduated with a B.Sc. (Honours) in Pharmacology from Aberdeen University then a PhD from University College London, where he worked with Professor Geoffrey Burnstock, FRS. These studies led to the division of P2 receptors into the P2X and P2Y subtypes. Following a postdoctoral position at Michigan State University, he was a Beit Research Memorial Fellow at Cambridge University, working with Graeme Henderson, before joining Strathclyde University, where he is currently an honorary reader.

His research interests are the pharmacological properties and physiological and pathophysiological functions of P2X and P2Y receptors, with particular reference at present to P2Y heteromultimer formation.

Charles is a Fellow of the British Pharmacological Society. He chairs the IUPHAR P2X receptor nomenclature sub-committee and sits on the P2Y receptor sub-committee. He is a past editor of the British Journal of Pharmacology and is now the editor-in-chief of Purinergic Signalling.


Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Doctor of Philosophy, Regulation of vascular tone by purine nucleosides and nucleotides, University of London

Award Date: 1 Jan 1984

Bachelor of Science, Honours B.Sc. Degree in Pharmacology, University of Aberdeen

Award Date: 1 Jan 1981


Dive into the research topics where Charles Kennedy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or